NERSHIP OLSTER ECONOMIC HOUT VIRGINIA Virginia is closing 2025 with a great deal of momentum in the biopharma advanced manufacturing space, bolstered by multibillion-dollar investments from Eli Lilly and Company, AstraZeneca, and Merck and Co. The recent announcements highlight Virginia’s greatest strengths in the advanced pharmaceutical manufacturing industry — workforce, partnership, and site development — and speak 50 CIVIL AND MUNICIPAL VOLUME 06, ISSUE 12
RkJQdWJsaXNoZXIy MTI5MjAx